Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapy

Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapy - Phase 2 study of definitive chemoradiotherapy for locally advanced esophageal cancer being responsive to induction chemotherapy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005295

Enrollment

Registered

2011-03-23

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal cancer

Interventions

chemoradiation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: untreated thoracic esophageal carcinoma patients cT2T3 N0 70 percent SUV max reduction in PET during chemotherapy FAP PS ECOG 01

Exclusion criteria

Exclusion criteria: patients with serous concomitant diseas patients with serious infectiou disease

Design outcomes

Primary

Measure	Time frame
Complete response rate	—

Secondary

Measure	Time frame
Adverse effact,Ovarall survival,Relapse free survival, Survaival free from esophageal resction response rate	—

Countries

Japan

Contacts

Public ContactMakoto Yamasaki

Graduate School of Medicine,Osaka University Department of Gastroenterolgical Surgery

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026